Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Adventrx reports ANX-530 safety data and plans NDA submission

Jan. 15, 2008

The immunosuppressant FTY-720 shows promise in hematological cancer

Jan. 15, 2008

ImmuPharma gains rights to nucleolin antagonist IPP-204106 for cancer

Jan. 14, 2008

Novacea scales back clinical development of anticancer prodrug banoxantrone

Jan. 14, 2008

Pfizer's pan-ERBB inhibitor shows preclinical efficacy in gefitinib-resistant lung cancer

Jan. 14, 2008

Paclitaxel plus bevacizumab combination active in metastatic breast cancer

Jan. 14, 2008

Pharmion and MethylGene initiate phase II clinical trial of MGCD-0103 with Vidaza

Jan. 11, 2008

FDA grants approval to Chemokine to initiate phase II trial of CTCE-9908 for liver cancer

Jan. 11, 2008

FDA lifts clinical hold on Vion's phase III trial of Cloretazine for acute AML

Jan. 11, 2008

FDA approves Can-Fite's IND application for phase I study of CF-102 for liver cancer

Jan. 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...